Caplight Directory>Companies>ImmunoForge Co., Ltd.-preview>Immunoforge


ImmunoForge Co., Ltd.

ImmunoForge Co., Ltd.

Private
SeoulN/Ahttps://immunoforge.com/

Last Round

Series C

Oct 1, 2025

Est. Valuation

$75.8M

Total Funding Raised

$38.58M

Company Overview

ImmunoForge Co., Ltd. is a biotechnology company that develops therapies for treating cancer and metabolic diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmunoForge Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImmunoForge Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series COct 1, 2025
Series BSep 1, 2021
Series A ExtensionAug 1, 2020
Series AFeb 1, 2019
SeedDec 1, 2017
View all Funding Rounds

ImmunoForge Co., Ltd. Investors

Notable investors and investment history

InvestorRounds
BNH INVESTMENTSeries B, Series A
Smilegate InvestmentSeries A
Company K PartnersSeries C, Series B, Series A
KB SecuritiesSeries B
Kiwoom InvestmentSeries B
Korea Omega Investment CorpSeries A
Korea Development BankSeries C
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Raised $9.5M from Company K Partners, LB Investment, and Korea Development Bank.

  • Sep 1, 2021

    $19M round with participation from KB Securities and Kiwoom Investment.

View all signals

ImmunoForge Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImmunoForge Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmunoForge Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2017
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.